Decreased percentages of naïve CD4+ T cells, naïve CD8+ T cells, CD4+ naïve/memory ratios, and CD4+CD45RA+CD45RO+ T cells and increased memory CD4+ T cells were observed in NSCLC patients, suggesting that the immune system was activated against cancer. This evidence concerns the gene CD8A and non-small cell lung carcinoma.